Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Editorial: Assessment and mana...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Editorial: Assessment and management of adverse drug reactions in oncology

Editorial: Assessment and management of adverse drug reactions in oncology

Bibliographic Details
Main Authors: Ping-Feng Tsai, Kevin Sheng-Kai Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Frontiers in Allergy
Subjects:
immune checkpoint inhibitor
immune-related adverse event
Stevens-Johnson syndrome
opportunistic infection
corticosteroid
Online Access:https://www.frontiersin.org/articles/10.3389/falgy.2023.1223078/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/falgy.2023.1223078/full

Similar Items

  • Impact of Glucocorticoid Use in Oncology in the Immunotherapy Era
    by: Laura Kalfeist, et al.
    Published: (2022-02-01)
  • Pembrolizumab-induced Stevens-Johnson syndrome-like reaction: An atypical clinical presentation
    by: Arjun Mahajan, BS, MS, et al.
    Published: (2024-12-01)
  • Stevens-Johnson syndrome and toxic epidermal necrolysis associated with immune checkpoint inhibitors: a systematic review
    by: Jia Zhou, et al.
    Published: (2024-07-01)
  • Tumor necrosis factor inhibitors enhance corticosteroid therapy for Stevens-Johnson syndrome and toxic epidermal necrolysis linked to immune checkpoint inhibitors: a prospective study
    by: Chun-Xia He, et al.
    Published: (2024-08-01)
  • Pharmacovigilance of Severe Cutaneous Adverse Drug Reactions
    by: Kriteeka Saini, et al.
    Published: (2022-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs